| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Adherence, safety, and choice of the monthly dapivirine vaginal ring or oral emtricitabine plus tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis among African adolescent girls and young women: a randomised, open-label, crossover trial
|
Nair, Gonasagrie
|
|
|
10 |
12 |
p. e779-e789
|
article
|
| 2 |
ART and cardiovascular-disease risk in people with HIV
|
Malvestutto, Carlos
|
|
|
10 |
12 |
p. e760-e761
|
article
|
| 3 |
Correction to Lancet HIV 2023; 10: e424–26
|
|
|
|
10 |
12 |
p. e762
|
article
|
| 4 |
Correction to Lancet HIV 2023; 10: e244–53
|
|
|
|
10 |
12 |
p. e762
|
article
|
| 5 |
Correction to Lancet HIV 2023; 10: e385–93
|
|
|
|
10 |
12 |
p. e762
|
article
|
| 6 |
Correction to Lancet HIV 2018; 5: e696–705
|
|
|
|
10 |
12 |
p. e762
|
article
|
| 7 |
Correction to Lancet HIV 2023; 10: e375–84
|
|
|
|
10 |
12 |
p. e762
|
article
|
| 8 |
Effect of implementation strategies on pre-exposure prophylaxis persistence among female sex workers in South Africa: an interrupted time series study
|
Rao, Amrita
|
|
|
10 |
12 |
p. e807-e815
|
article
|
| 9 |
Efficacy and safety of long-acting cabotegravir compared with daily oral tenofovir disoproxil fumarate plus emtricitabine to prevent HIV infection in cisgender men and transgender women who have sex with men 1 year after study unblinding: a secondary analysis of the phase 2b and 3 HPTN 083 randomised controlled trial
|
Landovitz, Raphael J
|
|
|
10 |
12 |
p. e767-e778
|
article
|
| 10 |
Highlights of the 19th European AIDS Conference
|
Gonzalez-Lopez, Adrian
|
|
|
10 |
12 |
p. e763
|
article
|
| 11 |
HIV pre-exposure prophylaxis and its implementation in the PrEP Impact Trial in England: a pragmatic health technology assessment
|
Sullivan, Ann K
|
|
|
10 |
12 |
p. e790-e806
|
article
|
| 12 |
Long-acting cabotegravir PrEP: a time for cautious optimism
|
Griffin, David WJ
|
|
|
10 |
12 |
p. e756-e757
|
article
|
| 13 |
LVCT Health: implementing PrEP in Kenya
|
Ligami, Christabel
|
|
|
10 |
12 |
p. e766
|
article
|
| 14 |
Making the most of a fertile PrEP landscape
|
The Lancet HIV,
|
|
|
10 |
12 |
p. e755
|
article
|
| 15 |
Planning for PrEP: are national surveillance data sufficient?
|
Rutstein, Sarah E
|
|
|
10 |
12 |
p. e759-e760
|
article
|
| 16 |
Post-exposure prophylaxis to prevent HIV: new drugs, new approaches, and more questions
|
Mayer, Kenneth H
|
|
|
10 |
12 |
p. e816-e824
|
article
|
| 17 |
PrEParing for choice in a new era of HIV prevention
|
Graybill, Lauren A
|
|
|
10 |
12 |
p. e757-e758
|
article
|
| 18 |
PrEP empowering female sex workers in Kenya
|
Ligami, Christabel
|
|
|
10 |
12 |
p. e764-e765
|
article
|
| 19 |
Programme science: a route to effective coverage and population-level impact for HIV and sexually transmitted infection prevention
|
McClarty, Leigh M
|
|
|
10 |
12 |
p. e825-e834
|
article
|
Journal description